Your browser doesn't support javascript.
loading
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.
Sonpavde, Guru; Wang, Mingjun; Peterson, Leif E; Wang, Helen Y; Joe, Teresa; Mims, Martha P; Kadmon, Dov; Ittmann, Michael M; Wheeler, Thomas M; Gee, Adrian P; Wang, Rong-Fu; Hayes, Teresa G.
Afiliación
  • Sonpavde G; Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX, USA; Michael E. DeBakey Veterans Affairs Medical Center, VA 111H, 2002 Holcombe Blvd, Houston, TX 77030, USA.
  • Wang M; Center for Inflammation and Epigenetics, The Methodist Hospital Research Institute and Weill Cornell Medical College of Cornell University, 6670 Bertner Street, Houston, TX 77030, USA.
  • Peterson LE; Center for Biostatistics, The Methodist Hospital Research Institute and Weill Cornell Medical College of Cornell University, Houston, TX, USA.
  • Wang HY; Center for Inflammation and Epigenetics, The Methodist Hospital Research Institute and Weill Cornell Medical College of Cornell University, 6670 Bertner Street, Houston, TX 77030, USA.
  • Joe T; Michael E. DeBakey Veterans Affairs Medical Center, VA 111H, 2002 Holcombe Blvd, Houston, TX 77030, USA.
  • Mims MP; Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX, USA.
  • Kadmon D; Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
  • Ittmann MM; Michael E. DeBakey Veterans Affairs Medical Center, VA 111H, 2002 Holcombe Blvd, Houston, TX 77030, USA; Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
  • Wheeler TM; Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
  • Gee AP; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Wang RF; Center for Inflammation and Epigenetics, The Methodist Hospital Research Institute and Weill Cornell Medical College of Cornell University, 6670 Bertner Street, Houston, TX 77030, USA.
  • Hayes TG; Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX, USA; Michael E. DeBakey Veterans Affairs Medical Center, VA 111H, 2002 Holcombe Blvd, Houston, TX 77030, USA.
Invest New Drugs ; 32(2): 235-242, 2014 Apr.
Article en En | MEDLINE | ID: mdl-23609828
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Vacunas contra el Cáncer / Neoplasias de la Próstata Resistentes a la Castración / Inmunoterapia / Proteínas de la Membrana / Antígenos de Neoplasias Tipo de estudio: Guideline Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Vacunas contra el Cáncer / Neoplasias de la Próstata Resistentes a la Castración / Inmunoterapia / Proteínas de la Membrana / Antígenos de Neoplasias Tipo de estudio: Guideline Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos